Morgan Stanley Maintains Spire(SR.US) With Hold Rating, Maintains Target Price $77
RBC Capital Maintains Spire(SR.US) With Hold Rating, Raises Target Price to $68
Morgan Stanley Maintains Spire(SR.US) With Hold Rating, Raises Target Price to $77
J.P. Morgan Sticks to Its Hold Rating for Spire (SR)
Ladenburg Thalmann Downgrades Spire(SR.US) to Sell Rating, Cuts Target Price to $60.5
Spire Inc Is Maintained at Equal-Weight by Wells Fargo
Spire Analyst Ratings
Wells Fargo Maintains Spire(SR.US) With Hold Rating, Raises Target Price to $73
Wells Fargo Initiates Spire(SR.US) With Hold Rating, Announces Target Price $73
Spire (SR) Gets a Hold From Wells Fargo
Ladenburg Thalmann Initiates Spire(SR.US) With Hold Rating, Announces Target Price $65.5
Spire Inc Is Maintained at Equal-Weight by Morgan Stanley
Spire Analyst Ratings
Morgan Stanley Maintains Spire(SR.US) With Hold Rating, Raises Target Price to $76
Morgan Stanley Sticks to Its Hold Rating for Spire (SR)
J.P. Morgan Keeps Their Buy Rating on Spire Healthcare (SPI)
Spire Healthcare (SPI) Receives a Buy From Barclays
Spire Global Analyst Ratings
Spire Global Analyst Ratings
Spire Global (SPIR) Was Downgraded to a Hold Rating at Raymond James